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Abstract
Despite recent therapeutic progress, cancer remains a major cause of death in industrialized countries. As 
a consequence, alternative treatments attract the attention of a growing number of patients. Among these therapies, 
the use of sodium bicarbonate to fight cancer has gained considerable interest. According to self-medication reports 
available on the internet, sodium bicarbonate is viewed by many patients as a simple, costless and efficient anti-cancer 
agent. Although no clinical study has demonstrated an anti-cancer activity of sodium bicarbonate up to date, emerging 
experimental reports indicate, that sodium bicarbonate may slow the progression of cancer. Here, we highlight the 
rationale to use sodium bicarbonate in cancer therapy and further enumerate experimental evidence for its anti-tumoral 
activity. Finally, we speculate about a future role of sodium bicarbonate in cancer therapy.
Keywords: Sodium bicarbonate; Cancer; Therapy; pH; Acidity; 
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Introduction
The incidence of cancer is rising worldwide and so is the need 
for adequate therapies. Improvements in surgery and chemo-
radiotherapies as well as novel treatment modalities including targeted 
therapies and immunotherapies have significantly prolonged survival 
of cancer patients. Nevertheless, cancer remains a lethal disease, 
in particular in advanced stages. Based on this perspective, cancer 
patients frequently turn to alternative medicine, either in the hope of 
cure or in order to relieve symptoms. Internet provides information 
on magical remedies, presumably curing cancer, hence encouraging 
cancer patients to self-medication. In this context, emerging interest 
is drawn to sodium bicarbonate. Multiple patients’ reports, blogs 
and physicians’ testimonials praise the anti-tumor activity of sodium 
bicarbonate on the internet. Different theories were raised to explain 
its anti-cancer properties. One example is the ability of sodium 
bicarbonate to buffer tumor acidity and hence block acidity induced 
tumor growth. Despite these frequent reports, clinical data on the role 
of sodium bicarbonate treatment in cancer is still missing. Nonetheless, 
emerging experimental data support a beneficial effect of sodium 
bicarbonate on tumor growth, underlining a possible role of sodium 
bicarbonate in cancer therapy. In this article, we review the rationale of 
using sodium bicarbonate in cancer by focusing on the effect of tumor 
acidity on cancer progression. We further highlight the experimental 
evidence for an anti-cancer efficacy of sodium bicarbonate. Finally, we 
underline the hurdles in using sodium bicarbonate in cancer patients.
The Effect of Tumor Acidity on Cancer Progression
The tumor microenvironment is a complex structure composed 
of different cell types besides cancer cells themselves [1]. In contrast 
to normal tissue, the physico-chemical microenvironment of solid 
tumors has its own features including areas of hypoxia and acidic pH 
[2,3]. The latter is a consequence of an increased production of acidity 
by tumor cells in combination with a poor vascular circulation and 
blood supply [4]. In turn, acidity profoundly influences the biology 
of tumors (Figure 1). In fact, acidity controls cancer cells in several 
aspects. Firstly, acidity can be mutagenic, presumably by inducing 
DNA double-strand breaks by reactive oxide species or by blocking 
the topoisomerase II [5-7]. Hence, acidic pH actively contributes to 
the genetic instability of cancer cells. Secondly, evidence suggest that 
acidity promotes metastasis formation. Indeed, melanoma cells pre-
exposed to acidic medium metastasized more frequently to the lungs 
when injected into the tail vein of mice [8-10]. This was associated with 
up-reguation of the proteolytic enzymes MMP-2, MMP-9, cathepsin 
B, and cathepsin L, suggesting that acidity favors basement membrane 
and extracellular matrix degradation by cancer cells [8,11]. Consistent 
with the observation that cancer cells display a more aggressive 
phenotype following exposure to acidity, it was reported that low pH 
values increase the motility and invasiveness of cancer cells [10,12]. In 
line with these observations, regions of highest tumor invasion were 
shown to feature lowest pH in a dorsal chamber window model [13]. 
Furthermore, acidic pH promotes the disruption of cell-cell junctions, 
an important step that allows tumor cells to move into the surrounding 
tissue [14]. Indirect evidence for a role of acidity in promoting tumor 
metastasis has also been reported. For example, a high expression of 
carbonic anhydrase IX, an enzyme that acidifies tumor extracellular 
pH, is associated with metastasis [15]. Besides, extracellular pH was 
predictive of metastasis in dogs presenting spontaneous sarcomas [16].
In addition to its effects on cancer cells, acidity influences the 
efficacy of conventional cancer therapies. For instance, the acidic 
extracellular pH reduces the uptake of weak base chemotherapeutics 
such as doxorubicin by decreasing its cellular uptake [17,18]. Similar 
observations were made for mitoxantrone and topotecan [19]. 
Furthermore, acidity was reported to contribute to resistance of cancer 
cells by increasing drug efflux through an augmented expression of 
p-glycoprotein [20]. Besides its influence on chemotherapies, acidity 
was shown to render cancer cell resistant to radiotherapy. Indeed, 
radiation induced cell death is reduced in cancer cells cultured in acidic 
medium compared to physiological medium [21-23]. The mechanism 
involves a prolonged G2 arrest after irradiation in acidity, resulting in 
increased DNA damage repair.
As mentioned above, the tumor microenvironment consists of 
several other cell types apart from cancer cells. Among these, immune 
cells play a major role in tumor rejection. Over time, cancer evades 
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antitumor immune response, enabling tumor progression [24]. Recent 
studies have shown that tumor acidity represents a hostile environment 
for tumor infiltrating T lymphocytes [25,26]. In vitro, exposing tumor-
specific CD8+ T lymphocytes to acidic pH promotes reversible anergy 
characterized by impaired cytolytic activity and cytokine secretion. 
In vivo, enhancing tumor pH with proton pump inhibitors increased 
the efficacy of immunotherapy, identifying acidity as a mechanism of 
immune escape [26]. Consistent with these observations, the increased 
production of lactic acid by tumor cells also markedly impedes the 
function of human T cells [27,28]. Furthermore, lactic acid modulates 
dendritic cell maturation and antigen presentation, which further 
contributes to immune escape of tumors [29]. The effect of lactic 
acid is not limited to the adaptive immune system but also influences 
innate immunity. Macrophages are among the most abundant cells 
present in the tumor microenvironment. Depending on the condition, 
they undergo a classical (M1) or alternative (M2) activation [30]. 
Whereas M1-polarized macrophages exhibit antitumor activity, M2-
polarized macrophages promote cancer growth. Recent findings have 
demonstrated that lactic acid induces an M2-like polarization of 
tumor-associated macrophages [31]. This effect seems to be mediated 
by acidity since macrophages cultured in low pH conditions acquire an 
M2 phenotype [32].
Finally, the effect of tumor acidity on endothelial cells has been 
reported but needs further characterization. Nevertheless, it was 
suggested that acidity would not impair the angiogenic response 
necessary for tumor growth. In the rat aortic ring model, acidity 
reduced the angiogenic response but did not block it [33]. In addition, 
lactic acid might also contribute to angiogenesis by inducing the 
production of pro-angiogenic factors such as interleukin-8 and bFGF 
in endothelial cells following its uptake through the lactate transporter 
MCT1 [34,35].
Sodium Bicarbonate: The Experimental Evidence
As mentioned above, tumor acidity favors tumor progression. 
Hence, therapeutic interventions that target acidity were explored 
in cancer [36,37]. Amidst these strategies, systemic buffers such as 
sodium bicarbonate were used successfully to increase intratumoral 
pH (Table 1). Initially, sodium bicarbonate was shown to increase 
tumoral pH in mice bearing breast tumor xenografts, resulting in an 
improved anti-cancer efficacy of doxorubicin [38]. The feasibility of 
using sodium bicarbonate was further demonstrated in mathematical 
models [39]. Computer simulations demonstrated that ingestion 
of sodium bicarbonate effectively decreases tumor acidity without 
modifying blood and tissue pH. Furthermore, the resulting change in 
tumoral pH decreases tumor growth and invasion. Additional studies 
in tumor mouse models confirmed these observations [40]. Breast 
tumor xenografts were generated in immunodeficient mice. Mice were 
then randomized into control and treatment groups receiving or not 
sodium bicarbonate in the drinking water. Mice provided with sodium 
bicarbonate lived significantly longer and displayed a reduction in 
number and size of metastases of the lung, bowel and diaphragm. Of 
note, sodium bicarbonate had no effect on primary tumor growth and 
did not induce significant toxicity. Magnetic resonance spectroscopy 
confirmed that sodium bicarbonate increases the intratumoral pH. 
Tumor acidity
T lymphocytes
CTL activity
Dendritic cells
DC maturation
Macrophages
M2 polarization
Genetic instability
Cancer cells
Metastasis
Motility
Invasiveness
Cancer therapies
Radioresistance
Uptake of weak base 
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Figure 1: Complex model of 3,4-DCQ-1-COOR with respiratory syncytial virus (RSV) fusion protein (PDB: 3IXT). R (within the red rectangle) represents any 
hydrophobic group. R is buried in a hydrophobic pocket formed by B/TYR87, B/ALA43, B/PRO40, and A/TYR91. B means basic. A means acidic.
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No disturbance of blood electrolytes was noted after treatment. In 
particular, it did not lead to metabolic alkalosis [40]. In the same study, 
sodium bicarbonate reduced liver metastasis of human breast cancer 
cells injected into the spleen. In addition, it also decreased metastasis 
formation following tail vein injection of PC3M human prostate 
cancer cells. In contrast, in the same model, sodium bicarbonate 
failed to significantly decrease metastasis when B16 mouse melanoma 
cells were injected. Although the precise mechanism underlying this 
discrepancy not being identified, authors speculated that, as B16 cells 
proliferated faster, their rates of acid production might simply overpass 
the buffering capacities of sodium bicarbonate [40].
The effect of sodium bicarbonate was also tested in a transgenic 
mice model of prostate cancer [41]. In this model, the oncoprotein 
SV40 T antigen is under the control of the probasin promoter, 
resulting in prostate intraepithelial neoplasia before the age of 5 
weeks and progressing to invasive cancer around the age of 5 to 8 
weeks [42]. When sodium bicarbonate was initiated after the age of 6 
weeks, this did not block prostate cancer progression; primary tumor 
growth characteristics of concerned mice were similar to the ones of 
untreated mice. In contrast, if started at the age of 4 weeks, sodium 
bicarbonate significantly reduced development of prostate cancer. At 
necropsy, prostate hyperplasia was present in most of these mice and 
30% displayed small cancer foci. Notably, the pH of early treated mice 
was significantly higher than in untreated or late treated mice. This 
suggests that, by targeting acidity in intraepithelial neoplasias, sodium 
bicarbonate may prevent the development of invasive prostate cancer.
Finally, sodium bicarbonate was also tested for its effect on tumor 
growth within a mouse dorsal skin window chamber [13]. It was 
reported that the growth of the human colon cancer cells HCT116 was 
significantly reduced by sodium bicarbonate. Furthermore, the ability 
of sodium bicarbonate to increase the tumor pH was demonstrated. 
More importantly, it was shown that, whereas pH values at the center 
of the tumor did not significantly vary between control and bicarbonate 
treated mice, they were markedly increased at the invasive front. This 
further suggests a role of sodium bicarbonate in reducing tumor 
invasion by targeting acidity.
Finally, sodium bicarbonate was shown to increase the anti-cancer 
efficacy of weak base chemotherapies, as their cellular uptake was 
improved by increased extracellular tumor pH. MCF-7 human breast 
cancer cells were injected into the mammary fat pads of immunodeficient 
mice, and tumor growth was monitored. Whereas tumor growth of 
mice treated with sodiumbicarbonate alone was similar to control 
mice, in combination, sodium bicarbonate significantly increased the 
anti-cancer efficacy of doxorubicin [38]. Similar results were reported 
for mitoxantrone in a mammary carcinoma mouse model [43].
Sodium Bicarbonate: Is it a Safe Remedy?
Major concerns exist regarding the systemic use of sodium 
bicarbonate in patients, principally the development of metabolic 
alkalosis and its complications as well as hypernatremia. In addition, 
abrupt cessation of sodium bicarbonate might also result in adverse 
effect. Interestingly, several articles exist in the literature reporting 
the toxicity of chronic ingestion of sodium bicarbonate [44-47]. 
Indeed, baking soda, a common household product containing 
sodium bicarbonate has frequently been taken as an antacid to 
relieve heartburn. As expected, excessive ingestion of baking soda 
results in serious electrolyte imbalance requiring medical attention. 
Gastrointestinal symptoms such as abdominal pain, diarrhea, vomiting 
are frequently reported in this patients coupled with other symptoms 
including lethargy and weakness [45]. Respiratory compensation was 
also noticed with blood hypercapnia. Adverse effects were already 
reported in patients taking less than two teaspoons of baking soda with 
one teaspoon containing 4.8 g of sodium bicarbonate [45].
Contrariwise, chronic administration of sodium bicarbonate 
without major side effects was reported in patients with sickle cell 
disease or chronic metabolic acidosis [48-50], suggesting that ingestion of 
sodium bicarbonate is feasible under medical supervision. Furthermore, 
sodium bicarbonate is part of cancer treatment in alternative medicine and 
seems to be well tolerated at a daily dose of 12 g per day [51]. Of note, 
a case report of a 79-year-old man with advanced renal cell carcinoma 
who discontinued conventional treatment and initiated a self-medication 
consisting of vitamins, supplements and 60 g of sodium bicarbonate daily 
for ten months revealed a good tolerance of this high dose of sodium 
bicarbonate without development of side effects [39].
Whereas chronic ingestion of sodium bicarbonate can induce 
toxicity, its administration over a short time period might be better 
tolerated. In this context, sodium bicarbonate could be used as an 
adjunct to weak base chemotherapies in order to increase their 
efficacy. Furthermore, it might be worth testing a combination of 
sodium bicarbonate with radiotherapy or immunotherapies, possibly 
improving their efficacy. Novel therapies are preferentially tested 
in patients with advanced stages of cancer that progressed under 
conventional treatment. Hence the probability to demonstrate the anti-
cancer efficacy of a new treatment might be lower, necessitating a large 
cohort to show an effect. The costs of such studies are generally high 
and funding may be a challenge. Since no financial profit is expected by 
the prescription of sodium bicarbonate, it might be even more difficult 
to find sponsors ready to invest in such studies.
Conclusions
Many internet testimonials report of self-medication of sodium 
bicarbonate by cancer patients. However, despite a scientific rationale 
Effects Model References
Increases tumor pH
•	 MCF-7 human breast cancer xenografts in mice
•	 CH3 murine mammary carcinoma
•	 Computer simulation
•	 MDA-MB-231 human breast cancer xenografts in mice
•	 MDA-MB-231 cancer cells grown in mice dorsal skin-fold window chambers
•	 HCT116 human colon cancer cells grown in mice dorsal skin-fold window chambers
[13,38,39,40,43]
Increases the efficacy of weak base chemotherapy •	 MCF-7 human breast cancer xenografts in mice
•	 CH3 murine mammary carcinoma [38,43]
Decreases metastasis
•	 MDA-MB-231 xenografts
•	 Intrasplenic injection of MDA-MB-231 cancer cells
•	 Tail vein injection of PC3M prostate cancer cells
[40]
Reduces tumor growth •	 Transgenic mouse model of prostate cancer
•	 HCT116 human colon cancer cells grown in mice dorsal skin-fold window chambers [13,41]
Table 1: Experimental evidences of the effects of sodium bicarbonate in cancer.
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to use bicarbonate as a cancer treatment and emerging pre-clinical 
studies pointing to its anti-cancer efficacy, physicians remain 
skeptical towards this approach. Concerns are raised with respect to 
its efficacy and safety. Future experimental studies are necessary to 
better characterize the mechanism underlying the effect of sodium 
bicarbonate in cancer. Furthermore, clinical trials are needed in order 
to demonstrate its activity either as single treatment or adjunct therapy 
in patients. In addition, the tolerance and safety of sodium bicarbonate 
needs to be investigated in patients. Of note, since the sale of sodium 
bicarbonate does not generate any financial benefit, readiness to test it 
in costly clinical trials might be very limited.
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